Literature DB >> 24371145

Small G proteins Rac1 and Ras regulate serine/threonine protein phosphatase 5 (PP5)·extracellular signal-regulated kinase (ERK) complexes involved in the feedback regulation of Raf1.

Matthew D Mazalouskas1, Raquel Godoy-Ruiz, David J Weber, Danna B Zimmer, Richard E Honkanen, Brian E Wadzinski.   

Abstract

Serine/threonine protein phosphatase 5 (PP5, PPP5C) is known to interact with the chaperonin heat shock protein 90 (HSP90) and is involved in the regulation of multiple cellular signaling cascades that control diverse cellular processes, such as cell growth, differentiation, proliferation, motility, and apoptosis. Here, we identify PP5 in stable complexes with extracellular signal-regulated kinases (ERKs). Studies using mutant proteins reveal that the formation of PP5·ERK1 and PP5·ERK2 complexes partially depends on HSP90 binding to PP5 but does not require PP5 or ERK1/2 activity. However, PP5 and ERK activity regulates the phosphorylation state of Raf1 kinase, an upstream activator of ERK signaling. Whereas expression of constitutively active Rac1 promotes the assembly of PP5·ERK1/2 complexes, acute activation of ERK1/2 fails to influence the phosphatase-kinase interaction. Introduction of oncogenic HRas (HRas(V12)) has no effect on PP5-ERK1 binding but selectively decreases the interaction of PP5 with ERK2, in a manner that is independent of PP5 and MAPK/ERK kinase (MEK) activity, yet paradoxically requires ERK2 activity. Additional studies conducted with oncogenic variants of KRas4B reveal that KRas(L61), but not KRas(V12), also decreases the PP5-ERK2 interaction. The expression of wild type HRas or KRas proteins fails to reduce PP5-ERK2 binding, indicating that the effect is specific to HRas(V12) and KRas(L61) gain-of-function mutations. These findings reveal a novel, differential responsiveness of PP5-ERK1 and PP5-ERK2 interactions to select oncogenic Ras variants and also support a role for PP5·ERK complexes in regulating the feedback phosphorylation of PP5-associated Raf1.

Entities:  

Keywords:  ERK; Feedback Phosphorylation; MAP Kinases (MAPKs); MEK; PP5; Rac; Raf; Ras; S100 Proteins; Small G Protein

Mesh:

Substances:

Year:  2013        PMID: 24371145      PMCID: PMC3924286          DOI: 10.1074/jbc.M113.518514

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  78 in total

1.  Modulation of Akt kinase activity by binding to Hsp90.

Authors:  S Sato; N Fujita; T Tsuruo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 2.  Signalling by protein phosphatases and drug development: a systems-centred view.

Authors:  Lan K Nguyen; David Matallanas; David R Croucher; Alexander von Kriegsheim; Boris N Kholodenko
Journal:  FEBS J       Date:  2012-03-14       Impact factor: 5.542

3.  Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress.

Authors:  K Morita; M Saitoh; K Tobiume; H Matsuura; S Enomoto; H Nishitoh; H Ichijo
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

4.  Regulation of Raf-1 activation and signalling by dephosphorylation.

Authors:  Amardeep S Dhillon; Sharon Meikle; Zihni Yazici; Manfred Eulitz; Walter Kolch
Journal:  EMBO J       Date:  2002-01-15       Impact factor: 11.598

5.  Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes.

Authors:  D C Schönwasser; R M Marais; C J Marshall; P J Parker
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

6.  The ERK Cascade: Distinct Functions within Various Subcellular Organelles.

Authors:  Inbal Wortzel; Rony Seger
Journal:  Genes Cancer       Date:  2011-03

7.  Extracellular signal-regulated kinase 2 is necessary for mesoderm differentiation.

Authors:  Yao Yao; Wei Li; Junwei Wu; Ursula A Germann; Michael S S Su; Keisuke Kuida; Diane M Boucher
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-17       Impact factor: 11.205

8.  1H, 13C and 15N NMR assignments and solution secondary structure of rat Apo-S100 beta.

Authors:  J C Amburgey; F Abildgaard; M R Starich; S Shah; D C Hilt; D J Weber
Journal:  J Biomol NMR       Date:  1995-09       Impact factor: 2.835

9.  Single and combined silencing of ERK1 and ERK2 reveals their positive contribution to growth signaling depending on their expression levels.

Authors:  Renaud Lefloch; Jacques Pouysségur; Philippe Lenormand
Journal:  Mol Cell Biol       Date:  2007-10-29       Impact factor: 4.272

10.  Bell-shaped and ultrasensitive dose-response in phosphorylation-dephosphorylation cycles: the role of kinase-phosphatase complex formation.

Authors:  Barbara Szomolay; Vahid Shahrezaei
Journal:  BMC Syst Biol       Date:  2012-04-24
View more
  10 in total

1.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

Review 2.  Four and a half LIM domain protein signaling and cardiomyopathy.

Authors:  Yan Liang; William H Bradford; Jing Zhang; Farah Sheikh
Journal:  Biophys Rev       Date:  2018-06-20

3.  Leishmania phosphatase PP5 is a regulator of HSP83 phosphorylation and essential for parasite pathogenicity.

Authors:  Brianna Norris-Mullins; Joseph S Krivda; Kathryn L Smith; Micah J Ferrell; Miguel A Morales
Journal:  Parasitol Res       Date:  2018-07-08       Impact factor: 2.289

Review 4.  Structure and function of the co-chaperone protein phosphatase 5 in cancer.

Authors:  Rebecca A Sager; Natela Dushukyan; Mark Woodford; Mehdi Mollapour
Journal:  Cell Stress Chaperones       Date:  2020-04-02       Impact factor: 3.667

5.  The Role of ARF6 in Biliary Atresia.

Authors:  Mylarappa Ningappa; Juhoon So; Joseph Glessner; Chethan Ashokkumar; Sarangarajan Ranganathan; Jun Min; Brandon W Higgs; Qing Sun; Kimberly Haberman; Lori Schmitt; Silvia Vilarinho; Pramod K Mistry; Gerard Vockley; Anil Dhawan; George K Gittes; Hakon Hakonarson; Ronald Jaffe; Shankar Subramaniam; Donghun Shin; Rakesh Sindhi
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

6.  Tissue factor pathway inhibitor-2 induced hepatocellular carcinoma cell differentiation.

Authors:  Ziwei Li; Yong Xu; Qin Wang; Changli Xie; Yincui Liu; Zhiguang Tu
Journal:  Saudi J Biol Sci       Date:  2016-09-21       Impact factor: 4.219

7.  Systematic Interrogation of the Temperature Perturbation in the Insulin Signaling Pathway for Optogenetic Stimulation.

Authors:  Qi Dong; Mizuki Endo; Genki Kawamura; Takeaki Ozawa
Journal:  Cells       Date:  2022-10-05       Impact factor: 7.666

8.  HSP90 activity is required for MLKL oligomerisation and membrane translocation and the induction of necroptotic cell death.

Authors:  A V Jacobsen; K N Lowes; M C Tanzer; I S Lucet; J M Hildebrand; E J Petrie; M F van Delft; Z Liu; S A Conos; J-G Zhang; D C S Huang; J Silke; G Lessene; J M Murphy
Journal:  Cell Death Dis       Date:  2016-01-14       Impact factor: 8.469

9.  Protein phosphatase 5 regulates titin phosphorylation and function at a sarcomere-associated mechanosensor complex in cardiomyocytes.

Authors:  Judith Krysiak; Andreas Unger; Lisa Beckendorf; Nazha Hamdani; Marion von Frieling-Salewsky; Margaret M Redfield; Cris G Dos Remedios; Farah Sheikh; Ulrich Gergs; Peter Boknik; Wolfgang A Linke
Journal:  Nat Commun       Date:  2018-01-17       Impact factor: 14.919

10.  TNFAIP8 promotes AML chemoresistance by activating ERK signaling pathway through interaction with Rac1.

Authors:  Yihua Pang; Yanan Zhao; Yan Wang; Xinlu Wang; Ruiqing Wang; Na Liu; Peng Li; Min Ji; Jingjing Ye; Tao Sun; Jingxin Li; Daoxin Ma; Fei Lu; Chunyan Ji
Journal:  J Exp Clin Cancer Res       Date:  2020-08-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.